MERZ AESTHETICS CELEBRATES THE 10th ANNIVERSARY OF RADIESSE. Radiesse Marks Key Milestone with Revealing Patient Survey Results
Merz Aesthetics, a division of Merz North America (U.S. affiliate of Merz Pharma Group) announced the 10-year anniversary of the launch of their flagship brand, Radiesse . Radiesse is a volumizing filler used in more than 60 countries, and is unique in its ability to provide instant lift and stimulate the natural production of collagen with just one injection. More than 6 million syringes have been purchased by professionals worldwide over the past ten years.
In celebration of the brand’s 10-year anniversary, Merz Aesthetics issued a Patient Survey to Radiesse patients to learn more about their experiences with the product. Radiesse users were surveyed in June of 2016.
“The majority of polled Radiesse patients self reported that they consistently choose Radiesse even when given recommendations to try other fillers,” said Jim Hartman, Vice President and US Head of Merz Aesthetics Marketing and OTC. “We look forward to continuing to deliver outstanding results to our loyal product users for years to come with the only volumizing filler shown to stimulate the natural production of collagen for a more refreshed appearance that can last up to a year or more in many patients.”
The Radiesse Patient Survey also revealed that Radiesse patients are very likely to recommend Radiesse to friends and family.
“Radiesse has been used for a decade and continues to make satisfied patients in my practice time after time,” said Dr Lawrence Bass, Medical Director, Bass Plastic Surgery PLLC. “When patients are choosing their filler products, they want natural-looking results, confidence and consistency in the outcome and a product they can trust. The positive results of this user survey are not surprising.”
Since its approval by the U.S. Food and Drug Administration (FDA) in 2006, Radiesse has provided a unique treatment option for moderate to severe facial wrinkles and folds such as nasolabial folds. Radiesse has proven to be an ideal volumizer, as it possesses higher levels of viscosity and elasticity than leading dermal fillers. It is differentiated by an advanced calcium-based microsphere technology that immediately replenishes lost volume and stimulates the production of a patient’s own natural collagen for long-lasting results.
Radiesse received U.S. FDA approval for hand augmentation to correct volume loss in the dorsum of the hands in June of 2015. Radiesse provides an immediate volumizing effect and can help to reduce the prominence of tendons and veins in the hands, delivering smooth, natural-looking results that can last up to 1 year.
To learn more about Radiesse on this milestone anniversary, please visit birthday.radiesse.com
About the Radiesse Patient Survey
The Radiesse Patient Survey was issued by Merz North America (Merz) directly to a list of self-reported Radiesse users who had provided their email addresses to Merz. The survey was distributed via email and completed on a widely available online platform. 685 consumers completed the survey, 560 of which were self-reported Radiesse users.
About Merz Aesthetics
Merz Aesthetics is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada. As part of the Merz Pharma Group of companies, our ambition is to become the most admired, trusted and innovative aesthetics and neurotoxin company. By developing products that improve patients’ health and help them to live better, feel better and look better, Merz will continue to make significant contributions to the well-being of individuals around the world. Merz Aesthetics is an important contributor to the
U.S. aesthetics space, offering a well-balanced product portfolio that includes the dermal fillers Radiesse and Belotero Balance® . To learn more about Merz’s full aesthetic portfolio, including their full line of aesthetic injectables, the energy- based Ultherapy® System and the NEOCUTIS skincare line, please visit www.merzusa.com/aesthetics-otc.
RADIESSE is a registered trademark of Merz North America, Inc. Merz Aesthetics is a trademark of Merz Pharma GmbH & Co. KGaA.
What are RADIESSE® and RADIESSE® (+)?
RADIESSE® and RADIESSE® (+) are dermal fillers that are used for smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases that extend from the corner of your nose to the corner of your mouth). RADIESSE® is also used for correcting volume loss in the back of the hands.
RADIESSE® and RADIESSE® (+) IMPORTANT SAFETY INFORMATION
Who should not use RADIESSE® or RADIESSE® (+)?
You should not use RADIESSE® or RADIESSE® (+) if you have an allergy to any component of the product, if you have a history of severe allergies, if you have a bleeding disorder, or if you are pregnant or breastfeeding. You should not use RADIESSE® (+) if you have an allergy to lidocaine or medicines like it.
What is the most important information I should know about RADIESSE® and RADIESSE® (+)?
One of the risks with using these products is unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious, and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. If you have changes in your vision, signs of a stroke (including sudden difficulty speaking, numbness or weakness in your face, arms, or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.
As with all procedures that involve an injection through the skin, there is a risk of infection.
Do not use RADIESSE® or RADIESSE® (+) if you have a skin infection until it has healed.
It is not known if RADIESSE® or RADIESSE® (+) is safe or effective in the lips, or in the area around the eyes.
The microspheres in RADIESSE® and RADIESSE® (+) can be seen in X-rays and CT Scans. It is very important that you tell your health care provider that you have had RADIESSE® or RADIESSE® (+) dermal filler.
If you have a history of herpes, you may experience a herpes breakout after receiving RADIESSE® or RADIESSE® (+).
Injection in the back of the hand may result in temporary difficulty performing activities. RADIESSE® may cause nodules, bumps or lumps in the back of the hand and can last up to 1 year.
You should minimize strenuous activity and avoid extensive sun or heat exposure for about 24 hours after treatment and until any swelling or redness has resolved.
What should I tell my doctor before using RADIESSE® or RADIESSE® (+)?
Tell your health care provider if you are taking blood thinners or medicines that can interfere with the clotting of blood, such as aspirin or warfarin. These medicines might make it more likely that you will experience bruising or bleeding at the injection site. Tell your health care provider if you have any diseases, injuries or disabilities of the hand, if you have a history forming large, raised scars or if you have had any other skin treatments such as skin peels.
What are the most common adverse events with RADIESSE® or RADIESSE® (+)?
The most common adverse events seen in clinical studies of RADIESSE® used in the hands include bruising, redness, swelling, pain, itching, nodules or bumps/lumps, difficulty performing activities, loss of sensation and other local side effects. The most common adverse events seen in clinical studies of RADIESSE® or RADIESSE® (+) used in the face include bruising, redness, swelling, pain, itching and other local side effects.
These are not all of the possible side effects with RADIESSE® or RADIESSE® (+). Merz collects information about adverse events seen with RADIESSE® and RADIESSE® (+) outside of clinical studies. These events are included in the RADIESSE® and RADIESSE® (+) Patient Information Guide based on an assessment of seriousness and potential causal relationship to RADIESSE® or RADIESSE® (+). Please see the Patient Information Guide available at www.radiesse.com for list of these events. Tell your health care provider about any side effects that bother you or do not go away.
Important: For full safety information, please visit www.Radiesse.com or call MyMerz Solutions at 1-844-469-6379
RADIESSE® and RADIESSE® (+) are available by prescription only.
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.
10.26.2016 [ 0 KB ]
Merz North America